Early detection for effective disease management.
Your baby’s first step to a healthy life.
Did You Know?
Screening for your newborn will facilitate early detection and treatment with the hopes of preventing and managing possible long-term effects on your baby’s health.
About 1 in every 1682 babies is expected to be born with an inherited metabolic disorder, which may cause developmental issues and lifelong complications such as mental retardation, physical disability and in some instances, death, if it is left untreated.1
About 1 in every 10 children may have asthmas.The chances of getting asthmas is higher if the siblings had asthmas-related indications.2
Autism spectrum disorder (ASD) cases are genetically related. The early detection may facilitate a faster access to intervention which can significantly improve child’s cognitive ability. 3
One in every 20 children may be suffering from hyperactivity, resulting in poor concentration, impulsive behavior or other illness which could have a significant impact on later life. 4
1Evaluation of the 18-month "Pilot Study of Newborn Screening for Inborn Errors of Metabolism" in Hong Kong. HK J Paediatric (New Series) 2020;25:16-22
2Childhood asthmas are genetically related. Hong Kong Asthma Society website. https://www.hkasthma.org.hk/hk/press-releases/926. Accessed June 18, 2020.
3Autism risk from inherited genes. Autism Speaks website. https://www.autismspeaks.org/. Accessed on February 20, 2023.
4General Prevalence of ADHD. Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) Organisation website. https://chadd.org/about-adhd/general-prevalence/. Accessed on February 20, 2023.
Early Detection for Effective Disease Management.
Your Baby’s First Step to a Healthy Life.
SUITABLE AS EARLY AS THE 10TH WEEK OF GESTATION
From a simple blood draw as early as 10 weeks into your pregnancy, NIPT services screens for the most common chromosomal abnormalities that can affect your developing baby’s future.
CORDLIFE BABY GENETIC SCREENING SUITABLE FOR NEWBORNS
Using SNP chromosomal microarray technology, Cordlife Baby Genetic Screening can identify more than 120 conditions caused by chromosomal abnormalities and disease-causing gene variants, providing you an expanded insights of your baby’s health condition.
Beyond cord blood, cord lining and cord tissue banking, Cordlife is committed to offer a comprehensive suite of diagnostics services for the customer and their family members at different stages of life including Non-Invasive Prenatal Testing, Baby Genetic Screening, and etc.